SIRT Yttrium-90

DRUG2 trials

Sponsors

Chinese University of Hong Kong, Tuen Mun Hospital

Conditions

Cholangio CarcinomaHepatocellular Carcinoma (HCC)

Phase 2

Treatment for Bile Duct Cancer in the Liver

CompletedNCT02167711

Chinese University of Hong KongCholangio Carcinoma

Start: 2014-09-17End: 2023-02-08Updated: 2023-04-21

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

RecruitingNCT07293468

Tuen Mun HospitalHepatocellular Carcinoma (HCC)

Start: 2024-04-01End: 2034-12-31Target: 106Updated: 2025-12-19

Related Papers

Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial

Liver Cancer2022-01-0119 citations